Cargando…

Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

BACKGROUND: The poor outcomes for patients diagnosed with acute myeloid leukemia (AML) are largely attributed to leukemia stem cells (LSCs) which are difficult to eliminate with conventional therapy and responsible for relapse. Thus, new therapeutic strategies which could selectively target LSCs in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yahui, Gao, Huier, Zhang, Yu, Li, Ye, Vasdev, Neil, Gao, Yingdai, Chen, Yue, Zhang, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034521/ https://www.ncbi.nlm.nih.gov/pubmed/27658462 http://dx.doi.org/10.1186/s13045-016-0327-5

Ejemplares similares

Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
por: Ding, Yahui, et al.
Publicado: (2021)

Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion
por: Si, Xiaohui, et al.
Publicado: (2016)

KDM4 inhibitor SD49-7 attenuates leukemia stem cell via KDM4A/MDM2/p21(CIP1) axis
por: Li, Yinghui, et al.
Publicado: (2022)

Triggering of Programmed Erythrocyte Death by Alantolactone
por: Alzoubi, Kousi, et al.
Publicado: (2014)

Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
por: Rasul, Azhar, et al.
Publicado: (2013)

TNFSF15 facilitates human umbilical cord blood haematopoietic stem cell expansion by activating Notch signal pathway
por: Ding, Yahui, et al.
Publicado: (2020)

E35 ablates acute leukemia stem and progenitor cells in vitro and in vivo
por: Chen, Yingyu, et al.
Publicado: (2020)

Targeting of the Alox12-12-HETE in Blast Crisis Chronic Myeloid Leukemia Inhibits Leukemia Stem/Progenitor Cell Function
por: Gao, Si, et al.
Publicado: (2020)

Microwave-assisted Extraction of Alantolactone and Isoalantolactone from Inula helenium
por: Zhao, Y. M., et al.
Publicado: (2015)

Selective STAT3 Inhibitor Alantolactone Ameliorates Osteoarthritis via Regulating Chondrocyte Autophagy and Cartilage Homeostasis
por: Pei, Wenbin, et al.
Publicado: (2021)

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
por: Cai, Yuan, et al.
Publicado: (2021)

Mitochondrial oxidative phosphorylation is dispensable for survival of CD34(+) chronic myeloid leukemia stem and progenitor cells
por: Yan, Jin-Song, et al.
Publicado: (2022)

Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia
por: Shi, Ce, et al.
Publicado: (2020)

Antioxidant Small Molecule Compound Chrysin Promotes the Self-Renewal of Hematopoietic Stem Cells
por: Li, Yinghui, et al.
Publicado: (2020)

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
por: Zhao, Haijun, et al.
Publicado: (2022)

Alantolactone inhibits cervical cancer progression by downregulating BMI1
por: Sun, Xiaodong, et al.
Publicado: (2021)

Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia
por: Niu, Xiaojia, et al.
Publicado: (2021)

Requirements for human haematopoietic stem/progenitor cells
por: Nan, Xue, et al.
Publicado: (2021)

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome
por: Houshmand, Mohammad, et al.
Publicado: (2021)

Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells
por: Wang, Jiazhen, et al.
Publicado: (2019)

Ultrasound-assisted extraction of alantolactone and isoalantolactone from Inula helenium roots
por: Trendafilova, Antoaneta, et al.
Publicado: (2010)

Alantolactone Enhances the Phagocytic Properties of Human Macrophages and Modulates Their Proinflammatory Functions
por: Gierlikowska, Barbara, et al.
Publicado: (2020)

Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway
por: Zhang, Yong, et al.
Publicado: (2020)

Levistilide A Promotes Expansion of Human Umbilical Cord Blood Hematopoietic Stem Cells by Enhancing Antioxidant Activity
por: He, Mei, et al.
Publicado: (2022)

Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia
por: Boyd, Allison L., et al.
Publicado: (2023)

Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells
por: Ding, Yushuang, et al.
Publicado: (2016)

Antineoplastic effects of CPPTL via the ROS/JNK pathway in acute myeloid leukemia
por: Gao, Hui-Er, et al.
Publicado: (2017)

In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features
por: Tusa, Ignazia, et al.
Publicado: (2020)

Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment
por: Bao, Shihui, et al.
Publicado: (2021)

Semisynthesis, an Anti-Inflammatory Effect of Derivatives of 1β-Hydroxy Alantolactone from Inula britannica
por: Chen, Lin, et al.
Publicado: (2017)

Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway
por: Ren, Yijing, et al.
Publicado: (2019)

The Hepatotoxicity of Alantolactone and Germacrone: Their Influence on Cholesterol and Lipid Metabolism in Differentiated HepaRG Cells
por: Zárybnický, Tomáš, et al.
Publicado: (2020)

Alantolactone inhibits stem-like cell phenotype, chemoresistance and metastasis in PC3 cells through STAT3 signaling pathway
por: Babaei, Ghader, et al.
Publicado: (2020)

Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia
por: Tanturli, Michele, et al.
Publicado: (2011)

Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways
por: Yang, Chunmei, et al.
Publicado: (2020)

Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS
por: Cao, Peihai, et al.
Publicado: (2019)

Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations
por: Gerber, Jonathan M., et al.
Publicado: (2013)

PB1785: DISCOVERY OF APPROVED LOW-TOXICITY AGENTS DISRUPTING ACUTE MYELOID LEUKEMIA STEM AND PROGENITOR CELLS
por: Meilstrup, J., et al.
Publicado: (2022)

Cell Contact with Endothelial Cells Favors the In Vitro Maintenance of Human Chronic Myeloid Leukemia Stem and Progenitor Cells
por: Torres-Barrera, Patricia, et al.
Publicado: (2022)

A conserved ZFX/WNT3 axis modulates the growth and imatinib response of chronic myeloid leukemia stem/progenitor cells
por: Zhang, Xiuyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ao7for3p9r7pn6qomhlbkcj95